Making Sense of Allergic Rhinitis: A Comprehensive Look at Causes, Co-Morbidities, and Effective Treatment Strategies

Rupal Patel Mansukhani, PharmD, and Lucio Volino, PharmD
Published Online: Tuesday, February 18, 2014

This activity is supported by an educational grant from Chattem, Inc.
Making Sense of Allergic Rhinitis: A Comprehensive Look at Causes, Co-Morbidities, and Effective Treatment Strategies

Rupal Patel Mansukhani, PharmD
Clinical Assistant Professor
Ernest Mario School of Pharmacy
Rutgers University
Piscataway, New Jersey

Lucio Volino, PharmD
Clinical Assistant Professor
Ernest Mario School of Pharmacy
Rutgers University
Piscataway, New Jersey

The following contributors have no relevant financial relationships with commercial interests to disclose.

Rupal Patel Mansukhani, PharmD
Lucio Volino, PharmD

Pharmacy Times Office of Continuing Professional Education
Planning Staff—David Heckard; Maryjo Dixon, RPh; Steve Lin, PharmD, RPh; and Donna Fausak

Pharmacy Times
Editorial Staff
—Bea Riemschneider and Kirk McKay

An anonymous peer reviewer is used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial inter-ests to disclose.

Educational Objectives
At the conclusion of this knowledge-based CPE activity, pharmacists should be bet-ter prepared to:
  • Review the incidence and basic pathophysiology of allergic rhinitis (AR).
  • Describe the common symptoms, presentation, and complications of AR.
  • Discuss current management of AR, including allergen avoidance, immunotherapy, and pharmacotherapy, including new and emerging dosage formulations.
  • Apply counseling strategies to help address common patient questions and misconceptions to achieve optimal symptom relief.
Release date: February 12, 2014
Expiration date: February 12, 2016
Target audience: Pharmacists
Type of activity: Knowledge
Estimated time to complete activity: 2 hours
Fee: Free

Click here to view this activity.

Description: Description: Description: Pharmacy Times/Ascend Media Office of Continuing Professional EducationPharmacy Times Office of Continuing Professional Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 2.0 contact hours (0.2 CEUs) under the ACPE universal activity number 0290-0000-14-004-H01-P. The activity is available for CE credit through February 12, 2016.

Latest Articles
Pharmacists might be surprised to learn that Pinterest is a hotbed for anti-vaccine sentiment.
The FDA has approved betamethasone dipropionate spray, 0.05%, as a treatment for mild to moderate plaque psoriasis in patients aged 18 years and older.
Medication errors injure thousands of patients annually, and while mistakes occur with all medication classes, those involving antiretroviral therapies are particularly troublesome.
Acute respiratory infections such as the common cold are often accompanied by cough and congestion caused by mucus hypersecretion.
Latest Issues